Skip to main content
SpringerLink
Log in

Biologic properties of a new synthetic adjuvant, muramyl dipeptide (MDP)

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adam, A., Ciorbaru, R., Ellouz. F., Petit, J.-F., Lederer, E.: Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem. Biophys. Res. Commun 56, 561 (1974)

    Google Scholar 

  2. Adam, A., Devys, M., Souvannavong, V., Lefrancier, P., Choay, J., Lederer, E.: Correlation of structure and adjuvant activity of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. Biochem. Biophys. Res. Commun. 72, 339 (1976)

    Google Scholar 

  3. Adam, A., Souvannavong, V., Lederer, E.: Non-specific MIF like activity induced by the synthetic immunoadjuvant: N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP). Biochem. Biophys. Res. Commun. 85, 684 (1978)

    Google Scholar 

  4. Audibert, F., Chedid, L., Lefrancier, P., Choay, J.: Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cell. Immunol. 21, 243 (1976)

    Google Scholar 

  5. Audibert, F., Chedid, L., Lefrancier, P., Choay, J., Lederer, E.: Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP). Ann. Immunol. (Paris) 128 C, 653 (1977)

    Google Scholar 

  6. Audibert, F., Chedid, L., Hannoun, C.: Augmentation de la réponse immunitaire au vaccin grippal par un glycopeptide synthétique adjuvant (N-acétyl-muramyl-L-alanyl-D-isoglutamine). C. R. Acad. Sci [0] Paris 285, 467 (1977)

    Google Scholar 

  7. Audibert, F., Heymer, B., Gros, C., Schleifer, K. H., Seidl, P. H., Chedid, L.: Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies. J. Immunol. 121, 1219 (1978)

    Google Scholar 

  8. Audibert, F., Carelli, C., Jolivet, M., Reichert, C., Chedid, L.: Rôle éventuel de certains anticorps (anti-peptidoglycane) du sérum humain normal ou pathologique dans differents effects biologiques des glycopeptides immunoadjuvants. In: Rencontre Biologique 1978, p. 35 Paris: Varia, 1978

    Google Scholar 

  9. Azuma, I., Sugimura, K., Taniyama, T., Yamawaki, M., Yamamura, Y., Kusumoto, S., Okada, S., Shiba, T.: Adjuvant activity of mycobacterial fractions: immunological properties of synthetic N-acetyl-muramyl dipeptide and the related compounds. Infect. Immun. 14, 18 (1976)

    Google Scholar 

  10. Azuma, I., Sugimura, K., Yamamura, Y., Kusumoto, S., Tarumi, Y., Shiba, T.: Adjuvant activity of synthetic cell wall peptidoglycan subunits to monoazobenzenarsonate--N-acetyl-L-tyrosine and bacterial α amylase in guinea pigs. Jpn. J. Microbiol. 20, 63 (1976)

    Google Scholar 

  11. Azuma, I., Sugimura, K., Yamawaki, M., Uemiya, M., Kusumoto, S., Okada, S., Shiba, T., Yamamura, Y.: Adjuvant activity of synthetic 6–0-“mycoloyl”-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds. Infect. Immun. 20, 600 (1978)

    Google Scholar 

  12. Barksdale, L., Kim, K. S.: Mycobacterium. Bacteriol. Rev. 41, 217 (1977)

    Google Scholar 

  13. Chedid, L.: Immunopharmacological activities of muramyl dipeptide, a synthetic mycobacterial analog. Paris: 7th International Congress Pharmacology, July 1978 (in press).

  14. Chedid, L., Audibert, F., Lefrancier, P., Choay, J., Lederer, E.: Modulation of the immune response by a synthetic adjuvant and analogs. Proc. Natl. Acad. Sci. U.S.A. 73, 2472 (1976)

    Google Scholar 

  15. Chedid, L., Audibert, F.: Activity in saline of chemically well defined non-toxic bacterial adjuvants. In: Immunopathology, VIIth International Symposium, Miescher, P.A., ed., p. 382. Basel: Schwabe 1976

    Google Scholar 

  16. Chedid, L., Audibert, F.: Recent advances in the use of the synthetic immunoadjuvants. Muramyl dipeptide and analogues. In: Microbiology 1977, Schlessinger, D., ed., p. 388. Washington, D.C.: American Society for Microbiology 1977

    Google Scholar 

  17. Chedid, L., Audibert, F., Johnson, A. G.: Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents. Prog. Allergy 25, 63 (1978)

    Google Scholar 

  18. Chedid, L., Carelli, C., Audibert, F.: Antigenicity of muramyl dipeptide derivatives. Cross reactivity between bacterial products and their synthetic adjuvant active analogs. In: Microbial infections and autoimmunity, Annual Basic Science Symposium, Friedman, H., Linna, T. J., ed., Eastern Pennsylvania Branch of the American Society for Microbiology (in press)

  19. Chedid, L., Parant, M., Parant, F., Lefrancier, P., Choay, J., Lederer, E.: Enhancement of non-specific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetyl-muramyl-L-alanyl-D-isoglutamine) and several analogs. Proc. Natl. Acad. Sci. U.S.A. 74, 2089 (1977)

    Google Scholar 

  20. Chedid, L., Parant, M., Parant, F.: Recent aspects of non-specific resistance and immunological adjuvants. Proceedings of the 4th European Immunology Meeting. Budapest: Akadémiai Kiado (in press)

  21. Damais, C., Parant, M., Chedid, L.: Non-specific activation of murine spleen cells in vitro by a synthetic immunoadjuvant (N-acetyl-muramyl-L-alanyl-D-isoglutamine). Cell. Immunol. 34, 49 (1977)

    Google Scholar 

  22. Damais, C., Parant, M., Chedid, L., Lefrancier, P., Choay, J.: In vitro spleen cell responsiveness to various analogs of MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice. Cell. Immunol. 35, 173 (1978)

    Google Scholar 

  23. Dinarello, C. A., Elin, R. J., Chedid, L., Wolff, S. M.: The pyrogenicity of synthetic adjuvants. J. Infect. Dis. 138, 760 (1978)

    Google Scholar 

  24. Ellouz, F., Adam, A., Ciorbaru, R., Lederer, E.: Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59, 1317 (1974)

    Google Scholar 

  25. Emori, K., Tanaka, A.: Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide. Infect. Immun. 19, 613 (1978)

    Google Scholar 

  26. Fevrier, M., Birrien, J. L., Leclerc, C., Chedid, L., Liacopoulos, P.: The macrophage, target cell of the synthetic adjuvant, muramyl dipeptide. Eur. J. Immunol. 8, 558 (1978)

    Google Scholar 

  27. Hadden, J., Englard, A., Sadlik, J. R., Hadden, E. M.: The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM 1213 on lymphocyte and macrophage proliferation and activation in vitro. Int. J. Immunopharmacol. (In press)

  28. Heymer, B., Finger, H., Wirsing, C. H.: Immunoadjuvant effects of the synthetic muramyl dipeptide (MDP), N-acetyl-muramyl-L-alanyl-D-isoglutamine. Z. Immunitaetsforsch. 155, 87 (1978)

    Google Scholar 

  29. Igarashi, T., Okada, M., Azuma, I., Yamamura, Y.: Adjuvant activity of synthetic N-acetyl-muramyl-L-alanyl-D-isoglutamine and related compounds on cell-mediated cytotoxicity in syngeneic mice. Cell. Immunol. 34, 270 (1977)

    Google Scholar 

  30. Juy, D., Chedid, L.: Comparison between macrophage activation and enhancement of non-specific resistance to tumors by mycobacterial immunoadjuvants. Proc. Natl. Acad. Sci. U.S.A. 72, 4105 (1975)

    Google Scholar 

  31. Kohashi, O., Pearson, C. M., Watanabe, Y., Kotani, S., Koga, T.: Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plantarum and analogous synthetic compounds. J. Immunol. 116, 1635 (1976)

    Google Scholar 

  32. Kotani, S., Kinoshita, F., Morisaki, I., Shimono, T., Okunaga, T., Takada, H., Tsujimoto, M., Watanabe, Y., Kato, K., Shiba, T., Kusumoto, S., Okada, S.: Immunoadjuvant activities of synthetic 6–0-acyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes. Biken J. 20, 95 (1977)

    Google Scholar 

  33. Kotani, S., Watanabe, Y., Kinoshita, F., Shimono, T., Morisaki, I., Shiba, T., Kusumoto, S., Tarumi, Y., Ikenaka, K.: Immunoadjuvant activities of synthetic N-acetyl-muramyl peptides or -amino acids. Biken J. 18, 105 (1975)

    Google Scholar 

  34. Kotani, S., Watanabe, Y., Kinoshita, F., Kato, K., Harada, K., Shiba, T., Kusumoto, S., Tarumi, Y., Ikenaka, K., Okada, S., Kawata, S., Yokogawa, K.: Gelation of the amoebocyte lysate of Tachypleus tridentatus by cell wall digest of several gram-positive bacteria and synthetic peptidoglycan subunits of natural and unnatural configurations. Biken J. 20, 5 (1977)

    Google Scholar 

  35. Kotani, S., Watanabe, Y., Shimono, T., Narita, T., Kato, K., Stewart-Tull, D. E. S., Kinoshita, F., Yokogawa, K., Kawata, S., Shiba, T., Kusumoto, S., Tarumi, Y.: Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic N-acetylmuramyl peptides. Z. Immunitaetsforsch. 149, 302 (1975)

    Google Scholar 

  36. Kotani, S., Watanabe, Y., Shimono, T., Harada, K., Shiba, T., Kusumoto, S., Yokogawa, K., Taniguchi, M.: Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl peptides or-amino acids. Biken J. 19, 9 (1976)

    Google Scholar 

  37. de Kozak, Y., Audibert, F., Thillaye, B., Chedid, L., Faure, J. P.: Effets d'adjuvants hydrosolubles d'origine mycobactérienne sur l'induction et la prévention de l'uvéo-rétinite autoimmune expérimentale chez le cobaye. Ann. Immunol. Paris (in press)

  38. Kusumoto, S., Ikenaka, K., Shiba, T.: Synthesis of N-acetyl muramyl-L-[U-14C]-alanyl-d-isoglutamine. Tetrahedron Letters 4055 (1977)

  39. Kusumoto, S., Okada, S., Shiba, T., Azuma, I., Yamamura, Y.: Synthesis of 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-iso-glutamine with immunoadjuvant activity. Tetrahedron Letters 4287 (1976)

  40. Kusumoto, S., Okada, S., Yamamoto, K., Shiba, T.: Synthesis of 6–0-acyl derivatives of immunoadjuvant active N-acetylmuramyl-L-alanyl-D-isoglutamine. Bull. Chem. Soc. Japan 51, 2122 (1978)

    Google Scholar 

  41. Kusumoto, S., Tarumi, Y., Ikenaka, K., Shiba, T.: Chemical synthesis of N-acetyl-muramyl peptides with partial structures of bacterial cell wall and their analogs in relation to immunoadjuvant activities. Bull. Chem. Soc. Japan 49, 533 (1976)

    Google Scholar 

  42. Kusumoto, S., Yamamoto, K., Shiba, T.: Synthesis of N-acetyl-β-D-glucosaminyl-(1–4)-N-acetylmuramyl-L-D-isoglutamine. Tetrahedron Letters, 4407 (1978)

  43. Leclerc, C., Audibert, F., Chedid, L.: Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins. Immunology 35, 963 (1978)

    Google Scholar 

  44. Leclerc, C., Bourgeois, E., Chedid, L.: Enhancement by MDP of in vitro nude mice responses to a T-dependent antigen. Immunol. Commun. 8 (1979) in press

  45. Leclerc, C., Juy, D., Bourgeois, E., Chedid, L.: In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP. Cell. Immunol. 44 (in press, 1979)

  46. Leclerc, C., Juy, D., Chedid, L.: Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: factors affecting the response. Cell. Immunol. 42 (1979) in press

  47. Leclerc, C., Löwy, I., Chedid, L.: Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes. Cell. Immunol. 38, 286 (1978)

    Google Scholar 

  48. Lederer, E.: Natural and synthetic immunostimulants related to the mycobacterial cell wall. In: Proceedings of the Vth International Symposium on Medicinal Chemistry. p. 257. Amsterdam: Elsevier Scientific Publishing Co. 1977

    Google Scholar 

  49. Lefrancier, P., Choay, J., Derrien, M., Lederman, I.: Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some N-acetyl-muramyl peptide analogs. Int. J. Pept. Protein Res. 9, 249 (1977)

    Google Scholar 

  50. Lefrancier, P., Derrien, M., Lederman, I., Nief, F., Choay, J., Lederer, E.: Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-iso-glutamine). Int. J. Pept. Protein Res. 11, 289 (1978)

    Google Scholar 

  51. Löwy, I., Bona, C., Chedid, L.: Target cells for the activity of a synthetic adjuvant: muramyl dipeptide. Cell. Immunol. 29, 195 (1977)

    Google Scholar 

  52. Masek, K., Kadlecova, O., Petrovicky, P.: Pharmacological activity of bacterial peptidoglycan: the effect on temperature and sleep in the rat. In: Toxins: Animal, plant and microbial Proceedings of the Fith International Symposium. Rosenberg, P., ed., p. 991. Oxford and New York: Pergamon Press 1978

    Google Scholar 

  53. Masek, K., Zaoral, M., Jezek, J., Straka, R.: Immunoadjuvant activity of synthetic N-acetyl-muramyl dipeptide. Experientia 34, 1363 (1978)

    Google Scholar 

  54. Merser, C., Sinay, P., Adam, A.: Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 66, 1316 (1975)

    Google Scholar 

  55. Nagai, Y.: Modulation of the immunologic response of myelin basis protein by extrinsic and intrinsic factors. Neurology 26, 45 (1976)

    Google Scholar 

  56. Nagai, Y., Akiyama, K., Suzuki, K., Kotani, S., Watanabe, Y., Shimono, T., Shiba, T., Kusumoto, K., Ikuta, F., Takeda, S.: Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis. Cell. Immunol. 35, 158 (1978)

    Google Scholar 

  57. Nauciel, C., Fleck, J.: Adjuvant activity of bacterial peptidoglycans. Z. Immunitaetsforsch. 149 S, 349 (1975)

    Google Scholar 

  58. Ohkuni, H., Norose, Y., Hayama, M., Kimura, Y., Kotani, S., Shiba, T., Kusumoto, S., Yokogawa, K., Kawata, S.: Adjuvant activities in production of reaginic antibody in mice of bacterial cell wall peptidoglycans or peptidoglycan subunits and of synthetic N-actylmuramyl dipeptides. Biken J. 20, 131 (1977)

    Google Scholar 

  59. Oppenheim, J. J., Togawa, A., Chedid, L., Mizel, S.: Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor. Cell. Immunol. (in press, 1979)

  60. Parant, M., Damais, C., Audibert, F., Parant, F., Chedid, L., Sache, E., Lefrancier, P., Choay, J. Lederer, E.: In vivo and in vitro stimulation of non-specific immunity by the β-D-p-aminophenyl glycoside of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP) and an oligomer prepared by cross-linking with glutaraldehyde. J. Infect. Dis. 138, 378 (1978)

    Google Scholar 

  61. Parant, M., Parant, F., Chedid, L.: Enhancement of the neonate's non-specific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant. Proc. Natl. Acad. Sci. U.S.A. 75, 3395 (1978)

    Google Scholar 

  62. Parant, M., Parant, F., Chedid, L., Yapo, A., Petit, J. F., Lederer, E.: Fate of 14C-labeled muramyl dipeptide, a synthetic immunoadjuvant, after administration to the mouse. Int. J. Immunopharmacol. 1, (1979) in press

  63. Parant, M., Parant, F., Chedid, L., Le Minor, L.: Immunostimulants bactériens et protection de la souris infectée par Klebsiella pneumoniae resistante aux antibiotiques par mutation ou par transfert de plasmides. Ann. Immunol. (Paris) 126 C, 319 (1975)

    Google Scholar 

  64. Parant, M., Sacquet, E.: Augmentation de la résistance a l'infection du souriceau conventionnel ou axénique apres une injection d'endotoxine. C. R. Acad. Sci. [D] (Paris) D 262, 1914 (1966)

    Google Scholar 

  65. Prunet, J., Birrien, J. L., Panijel, J., Liacopoulos, P.: On the mechanism of early recovery of specifically depleted lymphoid cell populations by non-specific activation of T-cells. Cell. Immunol. 37, 151 (1978)

    Google Scholar 

  66. Reese, R. T., Trager, W., Jensen, J. B., Miller, D. A., Tantravahi, R.: Immunization against malaria with antigen from Plasmodium falciparum cultivated in vitro. Proc. Natl. Acad. Sci. U.S.A. 75, 5665 (1978)

    Google Scholar 

  67. Reichert, C. M., Carelli, C., Jolivet, M., Audibert, F., Lefrancier, P., Chedid, L.: Synthesis of N-acetylmuramyl-L-alanyl-D-isoglutaminyl (MDP) containing conjugates and their use as hapten-carrier system. Immunology (in press)

  68. Siddiqui, W. A., Taylor, D. W., Kan, S. C., Kramer, K., Richmond-Crum, S. M., Kotani, S., Shiba, T., Kusumoto, S.: Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant. Science 201, 1237 (1978)

    Google Scholar 

  69. Souvannavong, V., Adam, A., Lederer, E.: Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant. Infect. Immun. 19, 966 (1978)

    Google Scholar 

  70. Specter, S., Friedman, H., Chedid, L.: Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes. Proc. Soc. Exp. Biol. Med. 155, 349 (1977)

    Google Scholar 

  71. Specter, S., Cimprich, R., Friedman, H., Chedid, L.: Stimulation of enhanced in vitro immune response by a synthetic adjuvant, muramyl dipeptide. J. Immunol. 120, 487 (1978)

    Google Scholar 

  72. Staber, F. G., Gisler, R. H., Schumann, G., Tarcsay, L., Schläfli, E., Dukor, P.: Modulation of myelopoiesis by different bacterial cell wall components: induction of colony-stimulating activity (by pure preparations, low-molecular-weight degradation products, and a synthetic low-molecular analog of bacterial cell wall components) in vitro. Cell. Immunol. 37, 174 (1978)

    Google Scholar 

  73. Sugimoto, M., Germain, R. N., Chedid, L., Benacerraf, B.: Enhancement of carrier-synthetic helper T-cell function by the synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP). J. Immunol. 120, 980 (1978)

    Google Scholar 

  74. Takada, H., Kotani, S., Kusumoto, S., Tarumi, Y., Ikenaka, K., Shiba, T.: Mitogenic activity of adjuvant-active N-acetyl-muramyl-L-alanyl-D-isoglutamine and its analogues. Biken J. 20, 81 (1977)

    Google Scholar 

  75. Tanaka, A., Nagao, S., Saito, R., Kotani, S., Kusumoto, S., Shiba, T.: Correlation of stereochemically specific structure in muramyl dipeptide between macrophage activation and adjuvant activity. Biochem. Biophys. Res. Comm. 77, 621 (1977)

    Google Scholar 

  76. Tanaka, A., Saito, R., Sugiyama, K., Morisaki, I., Kotani, S., Kusumoto, S., Shiba, T.: Adjuvant activity of synthetic N-acetyl-muramyl peptides in rats. Infect. Immun. 15, 332 (1977)

    Google Scholar 

  77. Togawa, A., Oppenheim, J. J., Mizel, S. B., Kirkpatrick, C., Chedid, L.: Transfer factor (TF) and other stimulants activate human macrophages to produce lymphocyte activation factor (LAF). Fed. Proc. 37, 1589 (1978)

    Google Scholar 

  78. Toullet, F., Audibert, F., Voisin, G. A., Chedid, L.: Production d'une orchiépididymite aspermatogénétique auto-immune chez le cobaye, a l'aide de différents adjuvants hydrosolubles. Ann. Immunol. (Paris) 128 C, 267 (1977)

    Google Scholar 

  79. Wahl, S. M., Wahl, L. M., McCarthy, J. B., Chedid, L., Mergenhagen, S. E.: Macrophage activation by mycobacterial water-soluble components and synthetic muramyl dipeptide. J. Immunol. (in press)

  80. Watson, J., Whitlock, C.: Effect of a synthetic adjuvant on the induction of primary immune responses in T-cell depleted spleen cultures. J. Immunol. 121, 383 (1978)

    Google Scholar 

  81. Webster, R. G., Glezen, W. P., Hannoun, C., Laver, W. G.: Potentiation of the immune response to influenza virus subunit vaccines. J. Immunol. 119, 2073 (1977)

    Google Scholar 

  82. Yamamoto, Y., Nagao, S., Tanaka, A., Koga, T., Onoue, K.: Inhibition of macrophage migration by synthetic muramyl dipeptide. Biochem. Biophys. Res. Commun. 80, 923 (1978)

    Google Scholar 

  83. Yamamura, Y., Azuma, I., Sugimura, K., Yamawaki, M., Kusumoto, S., Okada, S., Shiba, T.: Adjuvant activity of 6–0-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine. Gann 67, 867 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre National de la Recherche Scientifique, G.R.n° 31, and Institut Pasteur, F-75724, Paris, France

    Monique Parant

Authors
  1. Monique Parant
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parant, M. Biologic properties of a new synthetic adjuvant, muramyl dipeptide (MDP). Springer Semin Immunopathol 2, 101–118 (1979). https://doi.org/10.1007/BF00201976

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00201976

Keywords

Search

Navigation